AOK NORDOST - DIE GESUNDHEITSKASSE
- Country
- Germany
- Type
- Beneficiary
- Calls awarded
- 19
- Grants received
- 2
Funding record
- 2 grants on record
- €129,875 awarded in total
- 2018–2018 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
Calls from this organisation
- Abschluss nicht-exklusiver Liefervereinbarung mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open-House-Verfahrens" der AOK Nordost
- Apixaban
- Atomoxetin
- Doravirin
- Entecavir
- Interferon beta 1-a (Rebif)
- Ipratropium bromid
- Leuprorelin
- Miglustat
- Nevirapin
- Octreotid
- Pazopanib
- Pegfilgrastim
- Perampanel
- Perindopril, Amlodipin und Indapamid
Grants received
- Personalised Medicine by Predictive Modeling in Stroke for better Quality of Life
- Big Data for Medical Analytics
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Source: Datenservice Öffentlicher Einkauf (Bundesministerium für Wirtschaft und Klimaschutz). CC0 1.0 (CC-ZERO) — no conditions.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.